da Silva, L.L.; Aguiar, P.N., Jr.; Park, R.; Edelman Saul, E.; Haaland, B.; de Lima Lopes, G.
Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials. Cancers 2021, 13, 2614.
https://doi.org/10.3390/cancers13112614
AMA Style
da Silva LL, Aguiar PN Jr., Park R, Edelman Saul E, Haaland B, de Lima Lopes G.
Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials. Cancers. 2021; 13(11):2614.
https://doi.org/10.3390/cancers13112614
Chicago/Turabian Style
da Silva, Laercio Lopes, Pedro Nazareth Aguiar, Jr., Robin Park, Eduardo Edelman Saul, Benjamin Haaland, and Gilberto de Lima Lopes.
2021. "Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials" Cancers 13, no. 11: 2614.
https://doi.org/10.3390/cancers13112614
APA Style
da Silva, L. L., Aguiar, P. N., Jr., Park, R., Edelman Saul, E., Haaland, B., & de Lima Lopes, G.
(2021). Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials. Cancers, 13(11), 2614.
https://doi.org/10.3390/cancers13112614
